Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic Radiosurgery
Clinical trial NCT00833859 · TERMINATED
Trial details
- NCT number
- NCT00833859
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2010-03-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.